×
About 38,213 results

Calise & Sons Bakery, Inc. Recalls Golden Flax Scala Bread Because of Possible Health Risk
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/449628

On 11/23 Calise & Sons Bakery, Inc. produced Italian Scala Bread (Italian bread w/Sesame Seeds) and by error were packaged in a bag that says Golden Flax Seed Scala Bread, photos below. A total of 689 packages were produced that went out to markets in RI, MA, NH and CT. The packages have a white p

Fauci: 'Every Reason To Believe' Boosters Protect Against Omicron
https://www.medpagetoday.com/infectiousdisease/covid19/96008

Dec 3rd, 2021 - Vaccination with a booster dose of COVID vaccine is expected to offer "some degree of cross protection" against the Omicron variant, said NIAID Director Anthony Fauci, MD, during a White House COVID-19 Response Team briefing on Friday. While there are still a lot of unknowns when it comes to the new variant -- including how transmissible it is, the severity of disease it causes, and its ability...

SGLT2 inhibitor use tied to fewer atrial arrhythmias
https://www.mdedge.com/cardiology/article/249371/arrhythmias-ep/sglt2-inhibitor-use-tied-fewer-atrial-arrhythmias
Mitchel L. Zoler, PhD

Dec 2nd, 2021 - Patients with cardiac implantable electronic devices (CIEDs) who received treatment with an sodium-glucose cotransporter 2 inhibitor had significantly fewer atrial arrhythmia events, compared with those who never received such a drug, in a prospective analysis of nearly 14,000 patients with a device who were followed for an average of nearly 2 years. Dr.

BO-112 Plus Pembrolizumab Improves ORR in Advanced Melanoma After Progression on Anti–PD-1 Therapy
https://www.onclive.com/view/bo-112-plus-pembrolizumab-improves-orr-in-advanced-melanoma-after-progression-on-anti-pd-1-therapy

Dec 1st, 2021 - The addition of BO-112 to pembrolizumab (Keytruda) produced clinical benefit in patients with unresectable malignant melanoma who have experienced disease progression on anti–PD-1 therapy, according to data from the preliminary analysis of the phase 2 SPOTLIGHT-203 trial (NCT04570332) presented during the 2021 SITC Annual Meeting. Of 37 patients who were evaluable for response, the combinati...

US STOCKS-Wall St ends lower as taper acceleration worries pile onto virus angst
https://www.reuters.com/article/usa-stocks/us-stocks-wall-st-ends-lower-as-taper-acceleration-worries-pile-onto-virus-angst-idUSL1N2SL2VC

Nov 30th, 2021 - (For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) (Updates with close of U.S. market, adds commentary) Nov 30 (Reuters) - Wall Street’s main indexes closed lower on Tuesday after Federal Reserve Chair Jerome Powell signaled that the U.S. central bank would consider speeding up its withdrawal of bond purchases as inflation risks increase...

US STOCKS-Wall St sinks as taper acceleration worries pile onto virus angst
https://www.reuters.com/article/usa-stocks/us-stocks-wall-st-sinks-as-taper-acceleration-worries-pile-onto-virus-angst-idUSL1N2SL2PH

Nov 30th, 2021 - (For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Communications services, materials lead sector declines * Fed’s Powell floats dropping “transitory” label for inflation * U.S. consumer confidence ebbs in November * Indexes down: Dow 1.44%, S&P 1.34%, Nasdaq 1.25% (Updates prices, adds commentary, byline) By Devik Jain, Ambar Warrick ...

BRIEF-Goldman Sachs Chief Warns New York City's Future ‘Not Guaranteed’ - FT
https://www.reuters.com/article/brief-goldman-sachs-chief-warns-new-york/brief-goldman-sachs-chief-warns-new-york-citys-future-not-guaranteed-ft-idUSFWN2SL17A

Nov 30th, 2021 - Nov 30 (Reuters) - * GOLDMAN SACHS CHIEF WARNS NEW YORK CITY’S FUTURE ‘NOT GUARANTEED’ - FT * DAVID SOLOMON SAYS HIGH TAXES THREATEN NEW YORK’S STATUS AS GLOBAL BUSINESS DESTINATION- FT Further company coverage:

Elanco Animal Health to cut about 380 jobs globally
https://www.reuters.com/article/elanco-animal-jobs/elanco-animal-health-to-cut-about-380-jobs-globally-idUSL4N2SL33U

Nov 30th, 2021 - Nov 30 (Reuters) - Elanco Animal Health Inc said on Tuesday it would reduce about 380 positions globally, including some of its senior management, as a part of its restructuring effort. (Reporting by Amruta Khandekar; editing by Uttaresh.V)

Regeneron says COVID-19 drug could be less effective against Omicron variant
https://www.reuters.com/article/health-coronavirus-regeneron/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-idUSL4N2SL2Z7

Nov 30th, 2021 - Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc said on Tuesday prior analyses suggested its COVID-19 antibody drug could have reduced activity against the Omicron coronavirus variant. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

U.S. FDA panel to weigh Merck's COVID-19 antiviral drug
https://www.reuters.com/article/health-coronavirus-treatments-merck/u-s-fda-panel-to-weigh-mercks-covid-19-antiviral-drug-idUSL4N2SK3L5

Nov 30th, 2021 - Nov 30 (Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration will vote later on Tuesday on whether to recommend authorization of Merck & Co’s antiviral pill to treat COVID-19. The U.S. drugmaker reported on Friday that the oral medicine’s efficacy in reducing hospitalizations and deaths had dropped to 30% with data available from over 1,400 patients in its late-stage s...

Facebook says it disagrees with UK ruling on Giphy deal
https://www.reuters.com/article/giphy-ma-meta-platforms-response/facebook-says-it-disagrees-with-uk-ruling-on-giphy-deal-idUSL9N2Q500B

Nov 30th, 2021 - LONDON, Nov 30 (Reuters) - Facebook-owner Meta said on Tuesday it disagreed with the British competition regulator’s ruling that it must sell animated images platform Giphy. “We disagree with this decision,” A Meta spokesperson said. “We are reviewing the decision and considering all options, including appeal.” (Reporting by Paul Sandle; Editing by Alistair Smout)

Britain regulator directs Facebook to sell GIF maker Giphy
https://www.reuters.com/article/giphy-ma-meta-platforms-britain/britain-regulator-directs-facebook-to-sell-gif-maker-giphy-idUSL4N2SL2QB

Nov 30th, 2021 - Nov 30 (Reuters) - Britain’s competition regulator said on Tuesday it has directed Facebook owner Meta Platforms to sell animated images platform Giphy, after finding that the deal could harm social media users and UK advertisers. (Reporting by Yadarisa Shabong and Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta)

National Grid, Scottish Power to pay $211 mln to customers after Western Link probe
https://www.reuters.com/article/ntnl-grid-elec-ofgem/national-grid-scottish-power-to-pay-211-mln-to-customers-after-western-link-probe-idUSL4N2SL2OS

Nov 30th, 2021 - Nov 30 (Reuters) - Electricity companies National Grid Electricity Transmission and Scottish Power Transmission have agreed to pay 158 million pounds ($211.12 million) to customers and British energy regulator Ofgem for a two-year delay to Western Link project. Ofgem said the companies have acknowledge the project, an undersea electrical link in the UK, was delivered later that scheduled. The r...

Threatened by Omicron, EU states urged to test more as some lag
https://www.reuters.com/article/health-coronavirus-eu-testing/threatened-by-omicron-eu-states-urged-to-test-more-as-some-lag-idUSL8N2SK5N6

Nov 30th, 2021 - BRUSSELS (Reuters) - The European Union’s health commissioner has urged governments to boost efforts to detect coronavirus mutations, as some lag behind even as the new Omicron variant is detected around the bloc. The variant first found in southern Africa has now been identified in several European countries, but it is hard to track its spread as various countries do not carry out sufficient g...

Pub operator Marston's posts wider loss, withholds dividend
https://www.reuters.com/article/marstons-results/pub-operator-marstons-posts-wider-loss-withholds-dividend-idUSL4N2SL202

Nov 30th, 2021 - Nov 30 (Reuters) - Pub operator Marston’s Plc posted a bigger annual loss on Tuesday and withheld dividend citing potential for continuing uncertainty, as a new variant of the coronavirus identified last week threatens a sustained economic rebound. The company, which has about 1,500 pubs in the UK, still said bookings for the Christmas period was encouraging and in line with pre-pandemic levels...

Adolescents, THC, and the risk of psychosis
https://www.mdedge.com/psychiatry/article/249151/schizophrenia-other-psychotic-disorders/adolescents-thc-and-risk-psychosis
Elohor Sandra Otite, MD, Amrita Solanky, MD et. al.

Nov 29th, 2021 - Editor’s note: Readers’ Forum is a department for correspondence from readers that is not in response to articles published in Current Psychiatry. All submissions to Readers’ Forum undergo peer review and are subject to editing for length and style.

Vaping: Understand the risks
https://www.mdedge.com/psychiatry/article/249144/mixed-topics/vaping-understand-risks
Kaustubh G. Joshi, MD

Nov 29th, 2021 - From 2017 to 2018, the 30-day prevalence of “vaping” nicotine rose dramatically among 8th graders, 10th graders, 12th graders, college students, and young adults; the increase was the greatest among college students. 1 As vaping has become a common phenomenon in our society, it is prudent to have a basic understanding of what vaping is, and its potential health risks.

Calise & Sons Bakery, Inc. Recalls Golden Flax Scala Bread Because of Possible Health Risk
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/449629

On 11/23 Calise & Sons Bakery, Inc. produced Italian Scala Bread (Italian bread w/Sesame Seeds) and by error were packaged in a bag that says Golden Flax Seed Scala Bread, photos below. A total of 689 packages were produced that went out to markets in RI, MA, NH and CT. The packages have a white p

CLL Treatment May Increase Risk of Death From COVID-19
https://www.cancertherapyadvisor.com/home/cancer-topics/chronic-lymphocytic-leukemia/chronic-leukemia-cll-covid19-increase-death-risk-treatment/

Nov 29th, 2021 - Patients with chronic lymphocytic leukemia (CLL) and COVID-19 have a higher risk of death if they have received CLL treatment, according to a retrospective analysis published in Leukemia.1 Prior studies produced conflicting results regarding the impact of CLL treatment on COVID-19 outcomes. In one study, patients with recent or ongoing CLL treatment were more likely to have milder COVID-19, and...

BRIEF-Novavax Inc - Has Already Initiated Development Of A New Recombinant Spike Protein Based On The Known Genetic Sequence Of B.1.1.529
https://www.reuters.com/article/brief-novavax-inc-has-already-initiated/brief-novavax-inc-has-already-initiated-development-of-a-new-recombinant-spike-protein-based-on-the-known-genetic-sequence-of-b-1-1-529-idUSFWN2SH0F9

Nov 26th, 2021 - Nov 26 (Reuters) - Novavax Inc: * NOVAVAX INC - HAS ALREADY INITIATED DEVELOPMENT OF A NEW RECOMBINANT SPIKE PROTEIN BASED ON THE KNOWN GENETIC SEQUENCE OF B.1.1.529 * NOVAVAX - WILL HAVE NEW RECOMBINANT SPIKE PROTEIN BASED ON KNOWN GENETIC SEQUENCE OF B.1.1.529 READY FOR TESTING, MANUFACTURING WITHIN NEXT FEW WEEKS * NOVAVAX - RECENT DATA FROM PHASE 2 TRIAL LEAD US TO BELIEVE THAT OUR VACCINE ...